NICE Draft Guidance Recommends Bortezomib And Thalidomide For Multiple Myeloma
Links shared publicly online about this topic.
- 1,120total visits
NICE Draft Guidance Recommends Bortezomib And Thalidomide For Multiple Myeloma
View full resource at medicalnewstoday.com
Tags: Leprosy Medication, Cancer, Multiple Myeloma, Thalomid, Thalidomide
Most Recently Shared on August 26, 2010 at 7:00 pm By:
NICE Draft Guidance Recommends Bortezomib And Thalidomide For Multiple Myeloma http://mnt.to/3Dtv #cancer
NICE Draft Guidance Recommends Bortezomib And Thalidomide For Multiple Myeloma - QualityPoint Technologies
qualitypointtech.net — “In draft guidance published today (26 August 2010) NICE has recommended two treatments for multiple myeloma. Thalidomide (Thalidomide, Celgene) in combination with an alkylating agent and a corticosteroid is recommended for the first-line treatment of multiple myeloma in people for whom high-dose chemotherapy with stem cell transplantation is considered inappropriate. Bortezomib (Velcade, Janssen-Cilag) in combination with an alkylating agent and a corticosteroid is recommended as a treatment op” View full resource at qualitypointtech.net
Most Recently Shared on August 26, 2010 at 4:42 pm By:
NICE Draft Guidance Recommends Bortezomib And Thalidomide For Multiple Myeloma: In draft guidance published today ... http://bit.ly/aOYZk8
Advertisement
